Patent: 10,309,966

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,309,966

Title:	Personalized therapy of inflammation-associated cancer using methods of assessing the susceptibility of a subject to the treatment with EGFR inhibitors/antagonists
Abstract:	The present invention relates to in vitro methods of assessing the susceptibility or responsiveness of a subject to the treatment with an epidermal growth factor receptor (EGFR) inhibitor/antagonist, wherein the subject has been diagnosed or suspected of suffering from inflammation-associated cancer. These methods comprise determining the level of expression of EGFR in myeloid cells in a sample from the subject, wherein an expression of EGFR in the myeloid cells is indicative of the subject being susceptible to the treatment with an EGFR inhibitor/antagonist.
Inventor(s):	Sibilia; Maria (Vienna, AT)
Assignee:	Medizinische Universitat Wien (Vienna, AT)
Application Number:	15/312,252
Patent Claims:	see list of patent claims

Details for Patent 10,309,966

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Imclone	ERBITUX	cetuximab	VIAL; INTRAVENOUS	125084	001	2004-06-18	➤ Sign Up	Medizinische Universitat Wien (Vienna, AT)	2034-05-22	RX	Orphan	search
Amgen	VECTIBIX	panitumumab	INJECTABLE; IV (INFUSION)	125147	001	2006-09-27	➤ Sign Up	Medizinische Universitat Wien (Vienna, AT)	2034-05-22	RX		search
Amgen	VECTIBIX	panitumumab	INJECTABLE; IV (INFUSION)	125147	002	2006-09-27	➤ Sign Up	Medizinische Universitat Wien (Vienna, AT)	2034-05-22	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,309,966

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
European Patent Office	2947460	Nov 25, 2015
European Patent Office	3146342	Dec 19, 2018
European Patent Office	3146342	Mar 29, 2017
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.